Overexpression of GLUT1 in Colorectal Cancer is Independently Associated with Poor Prognosis
The International Journal of Biological Markers · 2011-07 · 26 (3) · 166-172
DOI: 10.5301/jbm.2011.8550 ↗Abstract
Background To investigate the expression of glucose transporter 1 (GLUT1) in colorectal cancer (CRC) and its relationship to clinicopathological variables. Methods The expression of GLUT1 in 163 primary tumors together with the corresponding normal mucosa, and 36 liver metastases was examined using real-time PCR. Results The mean value of GLUT1 was higher in primary tumors (50.390 ± 68.648) than in the corresponding normal mucosa (20.437 ± 28.703, p
EUVIMED